Document is current
Any future updates will be listed below
-
Authors
Zhang, Jie
Xian, Tong-Zhang
Wu, Ming-Xiao
Li, Chen
Pan, Qi
Guo, Li-Xin
-
Clinical Trials BETA
Clinical trials referenced in this document:
chictr-1800015658 at Chinese Clinical Trial RegistryDocuments that mention this clinical trial
-
Funding
Funding for this research was provided by:
AstraZeneca China and 3SBio Inc
- License Information
-
More Information
Article History
Received: 25 September 2019
Accepted: 16 March 2020
First Online: 25 April 2020
Ethics approval and consent to participate
: The research ethics committee of Beijing Hospital reviewed and approved the study protocol before the enrollment of patients (No. 2013 BJYYEC-017A-03). All procedures performed in studies involving human participants were in accordance with the ethics standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethics standards. All participants were informed of the details of the study and signed the corresponding consent forms.
: All data published here are under the consent for publication.
: The authors declare that they have no competing interests.
